中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
中国医药(600056) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入2,589,443.511,707,586.01826,274.463,414,835.962,609,973.00
营业收入2,589,443.511,707,586.01826,274.463,414,835.962,609,973.00
二、营业总成本2,498,322.181,643,827.95797,344.553,298,344.522,521,678.36
营业成本2,320,363.691,529,424.60738,733.293,048,959.392,331,705.86
营业税金及附加7,454.295,343.442,748.939,823.496,875.39
销售费用75,947.7049,467.6724,263.03109,922.5983,616.47
管理费用80,842.1554,006.8924,508.5797,524.7077,749.14
财务费用3,501.35-977.553,738.9019,592.3712,756.21
研发费用10,213.006,562.903,351.8312,521.988,975.29
资产减值损失----------
公允价值变动收益589.10589.1015.4812,746.69-110.85
投资收益1,289.95945.69755.91-6,501.68500.27
其中:对联营企业和合营企业的投资收益4,138.892,874.571,616.221,873.563,514.93
汇兑收益----------
三、营业利润82,376.2652,487.0230,465.0993,156.7985,056.47
加:营业外收入1,034.97468.37274.974,525.44976.64
减:营业外支出1,166.47883.15278.692,363.371,754.73
其中:非流动资产处置损失----------
四、利润总额82,244.7752,072.2430,461.3695,318.8584,278.38
减:所得税费用23,373.7014,539.537,741.3626,656.4622,186.58
五、净利润58,871.0737,532.7122,720.0068,662.3962,091.80
归属于母公司所有者的净利润45,476.3929,395.9416,637.9253,546.7744,714.83
少数股东损益13,394.688,136.776,082.0815,115.6217,376.97
六、每股收益
基本每股收益(元/股)0.30400.19650.11120.35800.2989
稀释每股收益(元/股)0.30400.19650.11120.35800.2989
七、其他综合收益61.40262.8888.50-36.25-354.53
八、综合收益总额58,932.4737,795.5922,808.5068,626.1461,737.27
归属于母公司所有者的综合收益总额45,537.7929,658.8216,726.4253,508.3744,360.31
归属于少数股东的综合收益总额13,394.688,136.776,082.0815,117.7717,376.97
下载全部历史数据到excel中 返回页顶